申请人:——
公开号:US20030028022A1
公开(公告)日:2003-02-06
Compounds which modulate chemokine receptor activities are disclosed. These compounds are preferably tertiary amines comprising tetrahydroquinoline and benzimidazole.
本发明揭示了调节
趋化因子受体活性的化合物。这些化合物通常为包含
四氢喹啉和
苯并咪唑的三级胺。